BIO Proposes Increased Base Rates For Drugs In 2002 Medicare OPPS

The Centers for Medicare & Medicaid Services should raise the base rates for drugs in the Medicare hospital outpatient prospective payment system to offset a 68.9% pro-rata reduction in "pass-through" payments, the Biotechnology Industry Organization contends